[go: up one dir, main page]

DE69019163D1 - Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma. - Google Patents

Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma.

Info

Publication number
DE69019163D1
DE69019163D1 DE69019163T DE69019163T DE69019163D1 DE 69019163 D1 DE69019163 D1 DE 69019163D1 DE 69019163 T DE69019163 T DE 69019163T DE 69019163 T DE69019163 T DE 69019163T DE 69019163 D1 DE69019163 D1 DE 69019163D1
Authority
DE
Germany
Prior art keywords
gamma interferon
medicament
manufacture
dependent asthma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69019163T
Other languages
English (en)
Other versions
DE69019163T2 (de
Inventor
Donald Leung
Raif Geha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23766250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69019163(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Application granted granted Critical
Publication of DE69019163D1 publication Critical patent/DE69019163D1/de
Publication of DE69019163T2 publication Critical patent/DE69019163T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69019163T 1989-12-01 1990-11-29 Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma. Revoked DE69019163T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44476389A 1989-12-01 1989-12-01
PCT/US1990/006971 WO1991007984A1 (en) 1989-12-01 1990-11-29 Treatment of atopic disorders with gamma-interferon

Publications (2)

Publication Number Publication Date
DE69019163D1 true DE69019163D1 (de) 1995-06-08
DE69019163T2 DE69019163T2 (de) 1995-09-07

Family

ID=23766250

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019163T Revoked DE69019163T2 (de) 1989-12-01 1990-11-29 Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma.

Country Status (8)

Country Link
EP (1) EP0502997B1 (de)
JP (1) JP2901017B2 (de)
AT (1) ATE121945T1 (de)
CA (1) CA2069870E (de)
DE (1) DE69019163T2 (de)
DK (1) DK0502997T3 (de)
ES (1) ES2071977T3 (de)
WO (1) WO1991007984A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
AU734887B2 (en) * 1997-03-06 2001-06-28 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis
DK1702623T3 (da) 1998-04-02 2009-01-19 Genentech Inc Anvendelse af interferon-gamma til behandling af hjertehypertrofi
CA2387089A1 (en) * 1999-11-10 2001-05-17 Mondobiotech Sa Interferon gamma for the treatment of asthma
JP4435465B2 (ja) * 2002-08-05 2010-03-17 長岡 均 抗アレルギー剤
EP1430902A1 (de) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Pharmazeutische Zusammensetzung enthaltend gamma-interferon zusammen mit molekularischen diagnostischen Methoden zur verbesserten Behandlung von Asthma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
ATE67675T1 (de) * 1986-06-17 1991-10-15 Biogen Inc Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.

Also Published As

Publication number Publication date
CA2069870C (en) 2000-08-22
JP2901017B2 (ja) 1999-06-02
EP0502997A1 (de) 1992-09-16
DK0502997T3 (da) 1995-07-17
CA2069870A1 (en) 1991-06-02
EP0502997B1 (de) 1995-05-03
DE69019163T2 (de) 1995-09-07
ES2071977T3 (es) 1995-07-01
WO1991007984A1 (en) 1991-06-13
JPH05501716A (ja) 1993-04-02
CA2069870E (en) 2005-01-11
ATE121945T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
DE50005985C5 (de) Verfahren zur herstellung von il-1ra, einem therapeutisch wirksamen protein, aus körperflüssigkeiten
Brooke Art therapy: An approach to working with sexual abuse survivors.
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
DE69524679D1 (de) Verwendung Rapamycin zur Herstellung eines Medikaments für die Verbeugung und Behandlung von hyperproliferativen Gefässerkrankheiten, eventuell in Kombination mit Mycophenolsäure
ATE217533T1 (de) Verwendung von il-12 und il-12 antagonisten zur herstellung eines arzneimittels für behandlung von autoimmunkrankheiten
DE69636085D1 (de) Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea
DE69513167D1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
ES2168006T3 (es) Factor neurotrofico ciliar modificado, metodo de fabricacion y metodos de utilizacion.
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
KR920700667A (ko) 세포간 점착분자 및 그의 결합리간드의 천식치료에의 이용
ATE208194T1 (de) Verwendung von selektiven liganden zur behandlung von hormonansprechenden krankheitzuständen
DE69019163D1 (de) Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma.
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
DE3587681D1 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
BR9612234A (pt) Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma
NO925048L (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
ATE249832T1 (de) Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
Sandyk Treatment with electromagnetic fields improves dual-task performance (talking while walking) in multiple sclerosis
Oppel Parathyroidectomy for ankylosing polyarthritis
David et al. Spinal and somatic growth in patients with juvenile chronic arthritis treated for up to 2 years with deflazacort
EP0183253A2 (de) Arzneimittel enthaltend einen aus den Peyer'schen Plaques hergestellten Organextrakt zur Behandlung bei Diabetes Mellitus und Pankreatitis
Tyler et al. Validation of pain assessment tools in children

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8331 Complete revocation